Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Focus on migraine prodrome: what should clinicians know?
Journal: Current opinion in neurology
Published: April 09, 2026
Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.
Journal: Cephalalgia : an international journal of headache
Published: April 07, 2026
The optimisation of migraine prevention: an urgent need.
Journal: The Lancet. Neurology
Published: January 28, 2026
Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial.
Journal: Pain and therapy
Published: December 16, 2025
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial.
Journal: Neurology and therapy
Published: November 13, 2025
The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN).
Journal: Cephalalgia : an international journal of headache
Published: November 06, 2025
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed.
Journal: European journal of neurology
Published: September 26, 2025
State of the art in the management of migraine-A response to the American College of Physicians migraine preventive treatment guideline.
Journal: Headache
Published: August 10, 2025
Last Updated: 09/26/2026